Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-05-22 @ 1:14 PM
Study NCT ID:
NCT00121251
Status:
COMPLETED
Last Update Posted:
2021-04-06
First Post:
2005-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: